Tobias, J.; Drinić, M.; Schmid, A.; Hladik, A.; Watzenböck, M.L.; Battin, C.; Garner-Spitzer, E.; Steinberger, P.; Kundi, M.; Knapp, S.;
et al. Combined Vaccination with B Cell Peptides Targeting Her-2/neu and Immune Checkpoints as Emerging Treatment Option in Cancer. Cancers 2022, 14, 5678.
https://doi.org/10.3390/cancers14225678
AMA Style
Tobias J, Drinić M, Schmid A, Hladik A, Watzenböck ML, Battin C, Garner-Spitzer E, Steinberger P, Kundi M, Knapp S,
et al. Combined Vaccination with B Cell Peptides Targeting Her-2/neu and Immune Checkpoints as Emerging Treatment Option in Cancer. Cancers. 2022; 14(22):5678.
https://doi.org/10.3390/cancers14225678
Chicago/Turabian Style
Tobias, Joshua, Mirjana Drinić, Anna Schmid, Anastasiya Hladik, Martin L. Watzenböck, Claire Battin, Erika Garner-Spitzer, Peter Steinberger, Michael Kundi, Sylvia Knapp,
and et al. 2022. "Combined Vaccination with B Cell Peptides Targeting Her-2/neu and Immune Checkpoints as Emerging Treatment Option in Cancer" Cancers 14, no. 22: 5678.
https://doi.org/10.3390/cancers14225678
APA Style
Tobias, J., Drinić, M., Schmid, A., Hladik, A., Watzenböck, M. L., Battin, C., Garner-Spitzer, E., Steinberger, P., Kundi, M., Knapp, S., Zielinski, C. C., & Wiedermann, U.
(2022). Combined Vaccination with B Cell Peptides Targeting Her-2/neu and Immune Checkpoints as Emerging Treatment Option in Cancer. Cancers, 14(22), 5678.
https://doi.org/10.3390/cancers14225678